Parkinson’s disease is said to be a degenerative disorder of the central nervous system that may frequently damage the sufferer’s motor skills, speech, and other functions. A new study reveals that individuals who consistently consume ibuprofen could decrease their threat of contracting Parkinson’s disease.
The study included around 1,36,474 people who did not suffer from Parkinson’s disease at the start of the study. Subjects were inquired regarding their intake of non-steroid anti-inflammatory drugs (NSAIDs), counting aspirin, ibuprofen and acetaminophen. Following six years, around 293 people had apparently developed Parkinson’s disease.
Xiang Gao, MD, with Harvard School of Public Health in Boston, remarked, “Ibuprofen was the only NSAID linked to a lower risk of Parkinson’s. Other NSAIDs and analgesics, including aspirin and acetaminophen, did not appear to have any effect on lowering a person’s risk of developing Parkinson’s. More research is needed as to how and why ibuprofen appears to reduce the risk of Parkinson’s disease, which affects up to one million people in the United States.”
The study discovered that habitual consumers of ibuprofen appeared to have 40 percent less chances to suffer from Parkinson’s disease as opposed to people who did not consume ibuprofen. Moreover, the odds of individuals who took elevated quantities of ibuprofen seemed to be quite less in developing Parkinson’s disease as against people who consumed smaller quantities of the drug. The outcomes appeared to be same, irrespective of age, smoking and caffeine intake.
The study would be presented at the American Academy of Neurology’s 62nd Annual Meeting in Toronto.